These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 31065877)
1. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis. Rau B; Brandl A; Thuss-Patience P; Bergner F; Raue W; Arnold A; Horst D; Pratschke J; Biebl M Gastric Cancer; 2019 Nov; 22(6):1226-1237. PubMed ID: 31065877 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients. Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213 [TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis. Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071 [TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674 [TBL] [Abstract][Full Text] [Related]
7. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852 [TBL] [Abstract][Full Text] [Related]
8. HIPEC and CRS in peritoneal metastatic gastric cancer - who really benefits? Hotopp T Surg Oncol; 2019 Mar; 28():159-166. PubMed ID: 30851894 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases. Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614 [TBL] [Abstract][Full Text] [Related]
10. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O; Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751 [TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study. Yarema R; Mielko J; Fetsych T; Ohorchak M; Skorzewska M; Rawicz-Pruszyński K; Mashukov A; Maksimovsky V; Jastrzębski T; Polkowski W; Gyrya P; Kovalchuk Y; Safiyan V; Karelin I; Kopetskiy V; Kolesnik O; Kondratskiy Y; Paskonis M Cancer Med; 2019 Jun; 8(6):2877-2885. PubMed ID: 31033239 [TBL] [Abstract][Full Text] [Related]
12. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455 [TBL] [Abstract][Full Text] [Related]
13. Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases. Steinhoff H; Acs M; Blaj S; Dank M; Herold M; Herold Z; Herzberg J; Sanchez-Velazquez P; Strate T; Szasz AM; Piso P World J Gastroenterol; 2023 May; 29(18):2850-2863. PubMed ID: 37274066 [TBL] [Abstract][Full Text] [Related]
14. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Mehta S; Schwarz L; Spiliotis J; Hsieh MC; Akaishi EH; Goere D; Sugarbaker PH; Baratti D; Quenet F; Bartlett DL; Villeneuve L; Kepenekian V; Eur J Surg Oncol; 2018 Nov; 44(11):1786-1792. PubMed ID: 29885982 [TBL] [Abstract][Full Text] [Related]
15. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center. Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715 [TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review. Tempfer CB; Kern P; Dogan A; Hilal Z; Rezniczek GA Clin Exp Metastasis; 2019 Aug; 36(4):321-329. PubMed ID: 31089843 [TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Allievi N; Bianco F; Pisano M; Montori G; Fugazzola P; Coccolini F; Lotti M; Mosconi S; Merelli B; Campanati L; Lucianetti A; Ansaloni L; Magnone S Updates Surg; 2023 Jan; 75(1):159-167. PubMed ID: 36371549 [TBL] [Abstract][Full Text] [Related]
18. Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases. Ljunggren M; Nordenvall C; Palmer G Eur J Surg Oncol; 2021 Nov; 47(11):2865-2872. PubMed ID: 34116900 [TBL] [Abstract][Full Text] [Related]
19. Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial. Glockzin G; Zeman F; Croner RS; Königsrainer A; Pelz J; Ströhlein MA; Rau B; Arnold D; Koller M; Schlitt HJ; Piso P Clin Colorectal Cancer; 2018 Dec; 17(4):285-296. PubMed ID: 30131226 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]